178 related articles for article (PubMed ID: 31270080)
21. Prognostic impact of the absence of biallelic deletion at the
Farah N; Kirkwood AA; Rahman S; Leon T; Jenkinson S; Gale RE; Patrick K; Hancock J; Samarasinghe S; Linch DC; Moorman AV; Goulden N; Vora A; Mansour MR
Haematologica; 2018 Jul; 103(7):e288-e292. PubMed ID: 29519867
[No Abstract] [Full Text] [Related]
22. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
[TBL] [Abstract][Full Text] [Related]
23. CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia.
Wang HP; Zhou YL; Huang X; Zhang Y; Qian JJ; Li JH; Li XY; Li CY; Lou YJ; Mai WY; Meng HT; Yu WJ; Tong HY; Jin J; Zhu HH
Am J Hematol; 2021 Mar; 96(3):312-319. PubMed ID: 33306218
[TBL] [Abstract][Full Text] [Related]
24. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
Delgado-Martin C; Meyer LK; Huang BJ; Shimano KA; Zinter MS; Nguyen JV; Smith GA; Taunton J; Winter SS; Roderick JR; Kelliher MA; Horton TM; Wood BL; Teachey DT; Hermiston ML
Leukemia; 2017 Dec; 31(12):2568-2576. PubMed ID: 28484265
[TBL] [Abstract][Full Text] [Related]
25. Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia.
La Starza R; Pierini V; Pierini T; Nofrini V; Matteucci C; Arniani S; Moretti M; Lema Fernandez AG; Pellanera F; Di Giacomo D; Storlazzi TC; Vitale A; Gorello P; Sammarelli G; Roti G; Basso G; Chiaretti S; Foà R; Schwab C; Harrison CJ; Van Vlierberghe P; Mecucci C
J Mol Diagn; 2020 May; 22(5):629-639. PubMed ID: 32142900
[TBL] [Abstract][Full Text] [Related]
26. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract][Full Text] [Related]
27. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
Schwartzman O; Savino AM; Gombert M; Palmi C; Cario G; Schrappe M; Eckert C; von Stackelberg A; Huang JY; Hameiri-Grossman M; Avigad S; Te Kronnie G; Geron I; Birger Y; Rein A; Zarfati G; Fischer U; Mukamel Z; Stanulla M; Biondi A; Cazzaniga G; Vetere A; Wagner BK; Chen Z; Chen SJ; Tanay A; Borkhardt A; Izraeli S
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4030-E4039. PubMed ID: 28461505
[TBL] [Abstract][Full Text] [Related]
28. Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
Zhou X; Gu Y; Han Q; Soliman M; Song C; Ge Z
Turk J Haematol; 2017 Dec; 34(4):366-368. PubMed ID: 28747286
[No Abstract] [Full Text] [Related]
29. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
Grossmann V; Haferlach C; Weissmann S; Roller A; Schindela S; Poetzinger F; Stadler K; Bellos F; Kern W; Haferlach T; Schnittger S; Kohlmann A
Genes Chromosomes Cancer; 2013 Apr; 52(4):410-22. PubMed ID: 23341344
[TBL] [Abstract][Full Text] [Related]
30. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia.
Porcu M; Kleppe M; Gianfelici V; Geerdens E; De Keersmaecker K; Tartaglia M; Foà R; Soulier J; Cauwelier B; Uyttebroeck A; Macintyre E; Vandenberghe P; Asnafi V; Cools J
Blood; 2012 May; 119(19):4476-9. PubMed ID: 22438252
[TBL] [Abstract][Full Text] [Related]
31. Does TAL-1 deletion contribute to the high incidence of T-cell acute lymphoblastic leukemia in South Indian patients?
Sudhakar N; Nirmala K; Rajalekshmy KR; Rajkumar T
Asian Pac J Cancer Prev; 2008; 9(1):127-30. PubMed ID: 18439091
[TBL] [Abstract][Full Text] [Related]
32. Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling.
Duval R; Bui LC; Mathieu C; Nian Q; Berthelet J; Xu X; Haddad I; Vinh J; Dupret JM; Busi F; Guidez F; Chomienne C; Rodrigues-Lima F
J Biol Chem; 2019 Aug; 294(33):12483-12494. PubMed ID: 31248982
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.
Rozovski U; Li P; Harris D; Ohanian M; Kantarjian H; Estrov Z
Cancer Med; 2014 Jun; 3(3):550-4. PubMed ID: 24678068
[TBL] [Abstract][Full Text] [Related]
34. Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.
Karlsson E; Veenstra C; Emin S; Dutta C; Pérez-Tenorio G; Nordenskjöld B; Fornander T; Stål O
Breast Cancer Res Treat; 2015 Aug; 153(1):31-40. PubMed ID: 26208487
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in
Sharp RC; Beg SA; Naser SA
Front Cell Infect Microbiol; 2018; 8():11. PubMed ID: 29423382
[TBL] [Abstract][Full Text] [Related]
36. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
[TBL] [Abstract][Full Text] [Related]
37. Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
Kim R; Boissel N; Touzart A; Leguay T; Thonier F; Thomas X; Raffoux E; Huguet F; Villarese P; Fourrage C; Passini L; Hunault M; Lepretre S; Chevallier P; Braun T; Lhéritier V; Chantepie S; Maury S; Escoffre M; Tavernier E; Chalandon Y; Graux C; Macintyre E; Ifrah N; Asnafi V; Dombret H; Lhermitte L;
Leukemia; 2020 Jul; 34(7):1730-1740. PubMed ID: 31992840
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of leukemia-induced non-coding activator RNA (LUNAR1) predicts poor outcome in pediatric T-acute lymphoblastic leukemia.
El-Khazragy N; Abdel Aziz MA; Hesham M; Matbouly S; Mostafa SA; Bakkar A; Abouelnile M; Noufal Y; Mahran NA; Abd Elkhalek MA; Abdelmaksoud MF
Immunobiology; 2021 Nov; 226(6):152149. PubMed ID: 34735923
[TBL] [Abstract][Full Text] [Related]
39. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia.
Huh HJ; Lee SH; Yoo KH; Sung KW; Koo HH; Jang JH; Kim K; Kim SJ; Kim WS; Jung CW; Lee KO; Kim SH; Kim HJ
Ann Hematol; 2013 May; 92(5):635-44. PubMed ID: 23354995
[TBL] [Abstract][Full Text] [Related]
40. Association of genetic variations in PTPN2 and CD122 with ocular Behcet's disease.
Zhang Q; Li H; Hou S; Yu H; Su G; Deng B; Qi J; Zhou C; Kijlstra A; Yang P
Br J Ophthalmol; 2018 Jul; 102(7):996-1002. PubMed ID: 29502070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]